General Forum, page-1311

I admit that I was blindsided by 3 things:

• Failure to get OTC
• Bad 4c and weak-sounding talk about a loan
• CC saying we should give them 6 months

Together, these issues let the market think, "There's no rush. Sell now and wait for a clear positive change."

So, here's what the market needs to decide:

• Will patients and doctors demand enough Pulse devices to compensate for the loss of OTC?
• Will revenue or deals or participation in the US listing come soon enough to negate the bad 4c?
• Is it fair to give them another 6 months given that they have already had plenty of time to prepare for this moment?